Vincent Paul Liptak Acquires 2,500 Shares of BlossomHill Therapeutics (NASDAQ:BLSM) Stock

BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) General Counsel Vincent Paul Liptak bought 2,500 shares of the company’s stock in a transaction dated Friday, August 7th. The stock was bought at an average price of $15.80 per share, for a total transaction of $39,500.00. Following the acquisition, the general counsel directly owned 109,212 shares of the company’s stock, valued at approximately $1,725,549.60. This represents a 2.34% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Vincent Paul Liptak also recently made the following trade(s):

• On Monday, August 10th, Vincent Paul Liptak purchased 2,200 shares of BlossomHill Therapeutics stock. The shares were bought at an average price of $16.00 per share, with a total value of $35,200.00.

BlossomHill Therapeutics Trading Up 3.3%

Shares of BlossomHill Therapeutics stock opened at $16.52 on Wednesday. BlossomHill Therapeutics, Inc. has a 12-month low of $15.25 and a 12-month high of $17.25.